Your browser doesn't support javascript.
loading
The CredibleMeds® list: Usage of QT interval prolonging drugs in Germany and discordances with prescribing information.
Then, Melanie I; Andrikyan, Wahram; Maas, Renke; Fromm, Martin F.
Affiliation
  • Then MI; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Andrikyan W; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Maas R; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Fromm MF; Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Br J Clin Pharmacol ; 88(1): 226-236, 2022 01.
Article in En | MEDLINE | ID: mdl-34156728
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Long QT Syndrome / Torsades de Pointes Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Clin Pharmacol Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Long QT Syndrome / Torsades de Pointes Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Clin Pharmacol Year: 2022 Document type: Article Affiliation country: Germany Country of publication: United kingdom